| Autor: |
Guseva, Alya, Au, Larry, Nouguez, Etienne |
| Předmět: |
|
| Zdroj: |
Socio-Economic Review; Apr2024, Vol. 22 Issue 2, p953-965, 13p |
| Abstrakt: |
"Capitalizing a Cure" by Victor Roy is a book that delves into the topic of high prescription drug prices in the US, with a specific focus on Gilead's Hepatitis C drug, sofosbuvir. Roy challenges the notion that high prices are justified by the cost of research and development, arguing that pharmaceutical companies prioritize financial speculation over drug research. The book also examines the influence of the financial industry on drug prices and calls for a reevaluation of the pharmaceutical industry's values, advocating for greater government involvement in drug development. Roy's work sheds light on the impact of financialization on science, drugs, and health, raising important questions about the values that shape drug pricing and access to life-saving medications. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
